Eur Rev Med Pharmacol Sci 2020; 24 (11): 6185-6194
DOI: 10.26355/eurrev_202006_21514

MiR-566 protects the malignant progression of breast cancer by negatively regulating WNT6

M.-C. Zhao, M.-M. Zhang, T. Li, Z.-H. Tao, Y.-Q. Du, L.-P. Wang, J. Zhang, B.-Y. Wang, X.-C. Hu

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Fudan University School of Medicine, Shanghai, China. huxichun2017@163.com


OBJECTIVE: To elucidate the relationship between microRNA-566 (miR-566) and prognosis in breast cancer (BC) and to clarify the influences of miR-566 and WNT6 in its locus region on BC progression.

PATIENTS AND METHODS: MiR-566 and WNT6 levels in 44 pairs of BC samples were detected by quantitative real-time polymerase chain reaction (qRT-PCR). The influences of miR-566 on clinical features and prognosis in BC patients were analyzed. According to the differential expressions of miR-566 in the tested BC cell lines, MDA-MB-231 and MCF-7 cells were selected for generating miR-566 knockdown and overexpression models, respectively. Cell counting kit-8 (CCK-8), 5-Ethynyl-2’-deoxyuridine (EdU) and transwell assays were conducted to explore the role of miR-566 in BC cell functions. Besides, the regulatory interaction between miR-566 and its downstream gene WNT6 was assessed by performing Dual-Luciferase reporter assay. Finally, the co-regulation of miR-566 and WNT6 in BC cell functions was examined.

RESULTS: MiR-566 was downregulated in BC tissues. BC patients with a low expression level of miR-566 were prone to suffering a large tumor size, advanced tumor grade, high incidence of lymphatic metastasis and poor prognosis. Overexpression of miR-566 weakened proliferative and migratory abilities in MCF-7 cells, whereas knockdown of miR-566 produced the opposite results in MDA-MB-231 cells. WNT6 was the target gene binding to miR-566, and they displayed a negative expression correlation in BC tissues. Regulatory effects of miR-566 on BC progression could be reversed by WNT6.

CONCLUSIONS: MiR-566 is closely related to tumor size, tumor grade, lymphatic metastasis and prognosis in BC. It protects the malignant progression of BC by negatively regulating WNT6.

Free PDF Download

To cite this article

M.-C. Zhao, M.-M. Zhang, T. Li, Z.-H. Tao, Y.-Q. Du, L.-P. Wang, J. Zhang, B.-Y. Wang, X.-C. Hu
MiR-566 protects the malignant progression of breast cancer by negatively regulating WNT6

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 11
Pages: 6185-6194
DOI: 10.26355/eurrev_202006_21514